Copyright
©The Author(s) 2016.
World J Clin Cases. Mar 16, 2016; 4(3): 88-93
Published online Mar 16, 2016. doi: 10.12998/wjcc.v4.i3.88
Published online Mar 16, 2016. doi: 10.12998/wjcc.v4.i3.88
Figure 1 Clinical course of Case 1 of viral breakthrough during the combination treatment with daclatasvir and asunaprevir.
RAVs: Resistance-associated variants; HCV: Hepatitis C virus; ALT: Alanine aminotransferase; UDCA: Ursodeoxycholic acid; DCV: Daclatasvir; ASV: Asunaprevir.
- Citation: Sato K, Yamazaki Y, Ohyama T, Kobayashi T, Horiguchi N, Kakizaki S, Kusano M, Yamada M. Combination therapy with daclatasvir and asunaprevir for dialysis patients infected with hepatitis C virus. World J Clin Cases 2016; 4(3): 88-93
- URL: https://www.wjgnet.com/2307-8960/full/v4/i3/88.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v4.i3.88